

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.17179526 |
| 2 | polyketide metabolic process (GO:0030638) | 6.06456781 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.06456781 |
| 4 | daunorubicin metabolic process (GO:0044597) | 6.06456781 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 6.06024275 |
| 6 | viral transcription (GO:0019083) | 5.14383864 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 4.92445844 |
| 8 | translational termination (GO:0006415) | 4.86520312 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.86343202 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.65265869 |
| 11 | protein neddylation (GO:0045116) | 4.62695955 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 4.59939134 |
| 13 | protein targeting to ER (GO:0045047) | 4.56440658 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.36003587 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.32495805 |
| 16 | regulation of mitochondrial translation (GO:0070129) | 4.08631216 |
| 17 | translational elongation (GO:0006414) | 4.07490083 |
| 18 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.93240707 |
| 19 | viral life cycle (GO:0019058) | 3.87258302 |
| 20 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.85996429 |
| 21 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.85746198 |
| 22 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.85746198 |
| 23 | interferon-gamma production (GO:0032609) | 3.84885849 |
| 24 | maturation of SSU-rRNA (GO:0030490) | 3.79511592 |
| 25 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.69121974 |
| 26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.65087687 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64933660 |
| 28 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.60454172 |
| 29 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.57783148 |
| 30 | cellular protein complex disassembly (GO:0043624) | 3.57435037 |
| 31 | negative regulation of ligase activity (GO:0051352) | 3.50066415 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.50066415 |
| 33 | DNA deamination (GO:0045006) | 3.47665722 |
| 34 | rRNA modification (GO:0000154) | 3.45082230 |
| 35 | peptidyl-histidine modification (GO:0018202) | 3.44196954 |
| 36 | ribosomal large subunit biogenesis (GO:0042273) | 3.42101629 |
| 37 | protein targeting to mitochondrion (GO:0006626) | 3.38324796 |
| 38 | rRNA methylation (GO:0031167) | 3.36493137 |
| 39 | translational initiation (GO:0006413) | 3.34838529 |
| 40 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.34296642 |
| 41 | platelet dense granule organization (GO:0060155) | 3.31240866 |
| 42 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.31000328 |
| 43 | translation (GO:0006412) | 3.26703780 |
| 44 | proteasome assembly (GO:0043248) | 3.25731141 |
| 45 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.21394251 |
| 46 | chromatin remodeling at centromere (GO:0031055) | 3.19669555 |
| 47 | CENP-A containing nucleosome assembly (GO:0034080) | 3.18587870 |
| 48 | establishment of protein localization to mitochondrion (GO:0072655) | 3.16115728 |
| 49 | intracellular protein transmembrane import (GO:0044743) | 3.15623867 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.15476971 |
| 51 | quinone metabolic process (GO:1901661) | 3.14198880 |
| 52 | DNA double-strand break processing (GO:0000729) | 3.13379361 |
| 53 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.12975663 |
| 54 | response to interferon-beta (GO:0035456) | 3.12724055 |
| 55 | protein localization to mitochondrion (GO:0070585) | 3.12024171 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.11127320 |
| 57 | oxidative phosphorylation (GO:0006119) | 3.09598514 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.09572654 |
| 59 | positive regulation of ligase activity (GO:0051351) | 3.09457655 |
| 60 | ATP biosynthetic process (GO:0006754) | 3.08363732 |
| 61 | pseudouridine synthesis (GO:0001522) | 3.04733430 |
| 62 | hydrogen ion transmembrane transport (GO:1902600) | 3.04120708 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03921858 |
| 64 | cellular component biogenesis (GO:0044085) | 3.03019643 |
| 65 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.00709774 |
| 66 | ATP synthesis coupled proton transport (GO:0015986) | 3.00348431 |
| 67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.00348431 |
| 68 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.98421731 |
| 69 | neutrophil activation involved in immune response (GO:0002283) | 2.98347102 |
| 70 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.98303658 |
| 71 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.98303658 |
| 72 | NADH dehydrogenase complex assembly (GO:0010257) | 2.98303658 |
| 73 | protein-cofactor linkage (GO:0018065) | 2.97642548 |
| 74 | protein complex disassembly (GO:0043241) | 2.97098026 |
| 75 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.96620995 |
| 76 | protein targeting to membrane (GO:0006612) | 2.96128705 |
| 77 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.95841017 |
| 78 | respiratory chain complex IV assembly (GO:0008535) | 2.95647401 |
| 79 | rRNA transcription (GO:0009303) | 2.94481359 |
| 80 | inner mitochondrial membrane organization (GO:0007007) | 2.89343017 |
| 81 | cullin deneddylation (GO:0010388) | 2.89072096 |
| 82 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.87185056 |
| 83 | formation of translation preinitiation complex (GO:0001731) | 2.86409647 |
| 84 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85750551 |
| 85 | histone mRNA metabolic process (GO:0008334) | 2.84577761 |
| 86 | protein deneddylation (GO:0000338) | 2.83760860 |
| 87 | base-excision repair, AP site formation (GO:0006285) | 2.83151130 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82678147 |
| 89 | proton transport (GO:0015992) | 2.82188470 |
| 90 | electron transport chain (GO:0022900) | 2.82151844 |
| 91 | maturation of 5.8S rRNA (GO:0000460) | 2.82005214 |
| 92 | respiratory electron transport chain (GO:0022904) | 2.81417287 |
| 93 | GPI anchor biosynthetic process (GO:0006506) | 2.81125985 |
| 94 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.81045706 |
| 95 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.81045706 |
| 96 | tRNA processing (GO:0008033) | 2.80977995 |
| 97 | mitochondrial transport (GO:0006839) | 2.79946882 |
| 98 | spliceosomal snRNP assembly (GO:0000387) | 2.79664753 |
| 99 | macromolecular complex disassembly (GO:0032984) | 2.77363980 |
| 100 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.76838206 |
| 101 | replication fork processing (GO:0031297) | 2.75944346 |
| 102 | hydrogen transport (GO:0006818) | 2.75446684 |
| 103 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.74101815 |
| 104 | rRNA metabolic process (GO:0016072) | 2.72715005 |
| 105 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.72531291 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71291416 |
| 107 | cytochrome complex assembly (GO:0017004) | 2.71104088 |
| 108 | protein complex biogenesis (GO:0070271) | 2.70133901 |
| 109 | signal peptide processing (GO:0006465) | 2.68082223 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68025953 |
| 111 | negative regulation of epidermis development (GO:0045683) | 2.63189502 |
| 112 | positive regulation of defense response to virus by host (GO:0002230) | 2.62782929 |
| 113 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.62342606 |
| 114 | cofactor catabolic process (GO:0051187) | 2.61993851 |
| 115 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61417205 |
| 116 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.59403099 |
| 117 | B cell mediated immunity (GO:0019724) | 2.58692045 |
| 118 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.57207486 |
| 119 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.57207486 |
| 120 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.56818045 |
| 121 | termination of RNA polymerase III transcription (GO:0006386) | 2.56818045 |
| 122 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.54793386 |
| 123 | cellular response to interferon-beta (GO:0035458) | 2.54585739 |
| 124 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.52091879 |
| 125 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.52091879 |
| 126 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.52091879 |
| 127 | reactive oxygen species biosynthetic process (GO:1903409) | 2.51644309 |
| 128 | somite rostral/caudal axis specification (GO:0032525) | 2.51177684 |
| 129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.50640120 |
| 130 | GDP-mannose metabolic process (GO:0019673) | 2.50030062 |
| 131 | mRNA catabolic process (GO:0006402) | 2.49617553 |
| 132 | cytidine deamination (GO:0009972) | 2.47959378 |
| 133 | cytidine metabolic process (GO:0046087) | 2.47959378 |
| 134 | cytidine catabolic process (GO:0006216) | 2.47959378 |
| 135 | DNA damage response, detection of DNA damage (GO:0042769) | 2.44796873 |
| 136 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.43405157 |
| 137 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.43199726 |
| 138 | DNA replication checkpoint (GO:0000076) | 2.42227332 |
| 139 | respiratory burst (GO:0045730) | 2.41824596 |
| 140 | positive regulation of isotype switching (GO:0045830) | 2.41437770 |
| 141 | coenzyme catabolic process (GO:0009109) | 2.40704906 |
| 142 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.40651033 |
| 143 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.40269616 |
| 144 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.39709027 |
| 145 | aerobic respiration (GO:0009060) | 2.39611509 |
| 146 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.39546358 |
| 147 | rRNA processing (GO:0006364) | 2.38966827 |
| 148 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.37808612 |
| 149 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.37808612 |
| 150 | response to peptidoglycan (GO:0032494) | 2.36204124 |
| 151 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.33873513 |
| 152 | phenylpropanoid metabolic process (GO:0009698) | 2.32922998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.69703728 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.17028666 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.61042884 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.59596435 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.30944506 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99726087 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.95701573 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91616633 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84792958 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84257267 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.62430590 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57415757 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55129224 |
| 14 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.54618348 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.51773921 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44478409 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44233323 |
| 18 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.34947248 |
| 19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.34947248 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.34947248 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27267638 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.22631924 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.21021109 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.11304015 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03793431 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.03580666 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96860619 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93406755 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.90793181 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88438576 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87089221 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.84998027 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84333596 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.84303474 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82992090 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80824879 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.79999418 |
| 38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.78833409 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.75103631 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73523862 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.73105403 |
| 42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71111950 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69334255 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.68133812 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.67971624 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67941532 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67524251 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67029591 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65832149 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64636746 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64495184 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63830351 |
| 53 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63706136 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55592624 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50891585 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47683478 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47218148 |
| 58 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.43344225 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.42580935 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40923337 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40267610 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.38471490 |
| 63 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38078292 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37905212 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37159839 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35892863 |
| 67 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35680000 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34278755 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33983543 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32520928 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31343548 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30561620 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27143239 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25722291 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25446177 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24794947 |
| 77 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24351564 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24179944 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22872427 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22417508 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22318180 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14777874 |
| 83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13995290 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13453427 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13121654 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13091434 |
| 87 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12915554 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10993843 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10721549 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10705201 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10637362 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09261699 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07818804 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06805071 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05774862 |
| 96 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05072848 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04757877 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04757877 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02456583 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02096707 |
| 101 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02096707 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01821674 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01690994 |
| 104 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01396435 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00894796 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00685385 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00516935 |
| 108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00453006 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99082873 |
| 110 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97667151 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97326622 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96138323 |
| 113 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95494715 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94842509 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93650253 |
| 116 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92938280 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91474699 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 0.91062213 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90828853 |
| 120 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.90129647 |
| 121 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89861014 |
| 122 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89774164 |
| 123 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.89423735 |
| 124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88822161 |
| 125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88741346 |
| 126 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88582917 |
| 127 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88254369 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88129551 |
| 129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87790498 |
| 130 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87256567 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87095184 |
| 132 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86809987 |
| 133 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86651789 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85972657 |
| 135 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85906366 |
| 136 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85844148 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85473439 |
| 138 | MYB_26560356_Chip-Seq_TH1_Human | 0.85279264 |
| 139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.84830861 |
| 140 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84684645 |
| 141 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84467825 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84152535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63289224 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.21510956 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 3.10410379 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.09236381 |
| 5 | MP0009785_altered_susceptibility_to | 3.07715123 |
| 6 | MP0005671_abnormal_response_to | 3.05363517 |
| 7 | MP0003436_decreased_susceptibility_to | 2.99815783 |
| 8 | MP0008058_abnormal_DNA_repair | 2.85891446 |
| 9 | MP0003011_delayed_dark_adaptation | 2.76717477 |
| 10 | MP0006082_CNS_inflammation | 2.73137825 |
| 11 | MP0003186_abnormal_redox_activity | 2.65518141 |
| 12 | MP0003724_increased_susceptibility_to | 2.61498427 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.54188145 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.49612141 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.41548289 |
| 16 | MP0004381_abnormal_hair_follicle | 2.40756215 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.37057912 |
| 18 | MP0005025_abnormal_response_to | 2.35531203 |
| 19 | MP0000685_abnormal_immune_system | 2.25048915 |
| 20 | MP0002254_reproductive_system_inflammat | 2.17727955 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.12435263 |
| 22 | MP0002132_abnormal_respiratory_system | 2.07535993 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.07507047 |
| 24 | MP0000372_irregular_coat_pigmentation | 2.06515693 |
| 25 | MP0010094_abnormal_chromosome_stability | 2.01042960 |
| 26 | MP0002102_abnormal_ear_morphology | 1.95990595 |
| 27 | MP0001790_abnormal_immune_system | 1.91287068 |
| 28 | MP0005387_immune_system_phenotype | 1.91287068 |
| 29 | MP0001800_abnormal_humoral_immune | 1.89596072 |
| 30 | MP0002723_abnormal_immune_serum | 1.87033988 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.79971409 |
| 32 | MP0002419_abnormal_innate_immunity | 1.79794917 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.77994007 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.77168404 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.75973643 |
| 36 | MP0001819_abnormal_immune_cell | 1.75383929 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.74309367 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.73367935 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.70230992 |
| 40 | MP0002405_respiratory_system_inflammati | 1.68572865 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.66754944 |
| 42 | MP0001853_heart_inflammation | 1.65653596 |
| 43 | MP0004147_increased_porphyrin_level | 1.64039434 |
| 44 | MP0002163_abnormal_gland_morphology | 1.64004714 |
| 45 | MP0005253_abnormal_eye_physiology | 1.63292588 |
| 46 | MP0004957_abnormal_blastocyst_morpholog | 1.59348367 |
| 47 | MP0008872_abnormal_physiological_respon | 1.55202859 |
| 48 | MP0008057_abnormal_DNA_replication | 1.53583204 |
| 49 | MP0004142_abnormal_muscle_tone | 1.51770149 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 1.51326928 |
| 51 | MP0000490_abnormal_crypts_of | 1.45557773 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.45206154 |
| 53 | MP0000716_abnormal_immune_system | 1.43329506 |
| 54 | MP0002398_abnormal_bone_marrow | 1.42855528 |
| 55 | MP0001529_abnormal_vocalization | 1.41170653 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.38045340 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.37164505 |
| 58 | MP0000858_altered_metastatic_potential | 1.36862444 |
| 59 | MP0003136_yellow_coat_color | 1.36398082 |
| 60 | MP0008995_early_reproductive_senescence | 1.34649312 |
| 61 | MP0000343_altered_response_to | 1.33852074 |
| 62 | MP0005389_reproductive_system_phenotype | 1.33284126 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.32620008 |
| 64 | MP0008469_abnormal_protein_level | 1.32610499 |
| 65 | MP0001919_abnormal_reproductive_system | 1.30802675 |
| 66 | MP0002722_abnormal_immune_system | 1.28494163 |
| 67 | MP0002429_abnormal_blood_cell | 1.27965489 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.27139672 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.26468572 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.25029890 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.23682866 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.23477693 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.23102597 |
| 74 | MP0002160_abnormal_reproductive_system | 1.22984788 |
| 75 | MP0002090_abnormal_vision | 1.21087598 |
| 76 | MP0009764_decreased_sensitivity_to | 1.19221340 |
| 77 | MP0002006_tumorigenesis | 1.17646667 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.16539844 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.16062736 |
| 80 | MP0003646_muscle_fatigue | 1.15340622 |
| 81 | MP0005408_hypopigmentation | 1.12662464 |
| 82 | MP0003787_abnormal_imprinting | 1.10966798 |
| 83 | MP0005310_abnormal_salivary_gland | 1.09769211 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.09061658 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.08801597 |
| 86 | MP0001293_anophthalmia | 1.07977831 |
| 87 | MP0005332_abnormal_amino_acid | 1.05224016 |
| 88 | MP0001905_abnormal_dopamine_level | 1.04692768 |
| 89 | MP0001533_abnormal_skeleton_physiology | 1.04068914 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 1.03050717 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.01405401 |
| 92 | MP0002166_altered_tumor_susceptibility | 1.00278552 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.99893833 |
| 94 | MP0003448_altered_tumor_morphology | 0.99807925 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.97731925 |
| 96 | MP0002210_abnormal_sex_determination | 0.97317822 |
| 97 | MP0003121_genomic_imprinting | 0.96257961 |
| 98 | MP0000631_abnormal_neuroendocrine_gland | 0.95404703 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.94913491 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.94150472 |
| 101 | MP0009697_abnormal_copulation | 0.93876085 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.93693283 |
| 103 | MP0003786_premature_aging | 0.93619862 |
| 104 | MP0002234_abnormal_pharynx_morphology | 0.93145985 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.93104196 |
| 106 | MP0002938_white_spotting | 0.91038804 |
| 107 | MP0005410_abnormal_fertilization | 0.90014965 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.89946539 |
| 109 | MP0005499_abnormal_olfactory_system | 0.89946539 |
| 110 | MP0002736_abnormal_nociception_after | 0.89864964 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.88849621 |
| 112 | MP0005451_abnormal_body_composition | 0.87926357 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86919028 |
| 114 | MP0001929_abnormal_gametogenesis | 0.85467380 |
| 115 | MP0000516_abnormal_urinary_system | 0.85318367 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.85318367 |
| 117 | MP0003693_abnormal_embryo_hatching | 0.84934636 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.84702812 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.84398382 |
| 120 | MP0000653_abnormal_sex_gland | 0.83421377 |
| 121 | MP0000427_abnormal_hair_cycle | 0.82768799 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.82331530 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.82260235 |
| 124 | MP0001545_abnormal_hematopoietic_system | 0.82260235 |
| 125 | MP0008007_abnormal_cellular_replicative | 0.81973654 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.80642836 |
| 127 | MP0003195_calcinosis | 0.80139768 |
| 128 | MP0001145_abnormal_male_reproductive | 0.79686409 |
| 129 | MP0009763_increased_sensitivity_to | 0.78882070 |
| 130 | MP0008873_increased_physiological_sensi | 0.77993152 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.77909840 |
| 132 | MP0000703_abnormal_thymus_morphology | 0.77603251 |
| 133 | MP0002009_preneoplasia | 0.77007654 |
| 134 | MP0003077_abnormal_cell_cycle | 0.76968173 |
| 135 | MP0001119_abnormal_female_reproductive | 0.76806676 |
| 136 | MP0000358_abnormal_cell_content/ | 0.76771510 |
| 137 | MP0003828_pulmonary_edema | 0.76272534 |
| 138 | MP0001485_abnormal_pinna_reflex | 0.76010964 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.76001609 |
| 140 | MP0004947_skin_inflammation | 0.75858904 |
| 141 | MP0001873_stomach_inflammation | 0.75758983 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.75252956 |
| 143 | MP0003252_abnormal_bile_duct | 0.75164787 |
| 144 | MP0003137_abnormal_impulse_conducting | 0.74116142 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72570005 |
| 146 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72541700 |
| 147 | MP0001727_abnormal_embryo_implantation | 0.72197594 |
| 148 | MP0005164_abnormal_response_to | 0.71624261 |
| 149 | MP0005266_abnormal_metabolism | 0.71424535 |
| 150 | MP0005257_abnormal_intraocular_pressure | 0.70880514 |
| 151 | MP0001984_abnormal_olfaction | 0.70738406 |
| 152 | MP0000313_abnormal_cell_death | 0.68805893 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.68301875 |
| 154 | MP0005390_skeleton_phenotype | 0.68046983 |
| 155 | MP0001324_abnormal_eye_pigmentation | 0.67403934 |
| 156 | MP0001764_abnormal_homeostasis | 0.64998676 |
| 157 | MP0000678_abnormal_parathyroid_gland | 0.63941863 |
| 158 | MP0003718_maternal_effect | 0.62464809 |
| 159 | MP0003866_abnormal_defecation | 0.62459633 |
| 160 | MP0004043_abnormal_pH_regulation | 0.62271026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.43612943 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.32614538 |
| 3 | 3-Methylglutaconic aciduria (HP:0003535) | 4.21147746 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86869142 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.83923528 |
| 6 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.80648474 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.71468488 |
| 8 | Multiple enchondromatosis (HP:0005701) | 3.67919665 |
| 9 | Type I transferrin isoform profile (HP:0003642) | 3.59791656 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.51627483 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 3.46646461 |
| 12 | Reticulocytopenia (HP:0001896) | 3.45783359 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.35292622 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.31207727 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.30936536 |
| 16 | Acute encephalopathy (HP:0006846) | 3.27764248 |
| 17 | Aplastic anemia (HP:0001915) | 3.24157773 |
| 18 | Hepatic necrosis (HP:0002605) | 3.20964185 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.13425068 |
| 20 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.13236472 |
| 21 | Increased CSF lactate (HP:0002490) | 3.12168145 |
| 22 | Poor head control (HP:0002421) | 3.08426415 |
| 23 | Increased IgM level (HP:0003496) | 3.08330059 |
| 24 | Pallor (HP:0000980) | 3.03240841 |
| 25 | Methylmalonic acidemia (HP:0002912) | 3.02639204 |
| 26 | Myositis (HP:0100614) | 3.00774667 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.98009410 |
| 28 | Exertional dyspnea (HP:0002875) | 2.96767045 |
| 29 | Partial duplication of thumb phalanx (HP:0009944) | 2.95034842 |
| 30 | Petechiae (HP:0000967) | 2.92428438 |
| 31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.89513694 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.89513694 |
| 33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.85544910 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.83727882 |
| 35 | Abnormality of glycolysis (HP:0004366) | 2.81510998 |
| 36 | Increased serum pyruvate (HP:0003542) | 2.81510998 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.72834382 |
| 38 | Pancreatic cysts (HP:0001737) | 2.70745276 |
| 39 | Macrocytic anemia (HP:0001972) | 2.69448914 |
| 40 | Renal cortical cysts (HP:0000803) | 2.67328544 |
| 41 | Orchitis (HP:0100796) | 2.67246871 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.66824344 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 2.66824344 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.64880380 |
| 45 | Methylmalonic aciduria (HP:0012120) | 2.64407425 |
| 46 | Congenital, generalized hypertrichosis (HP:0004540) | 2.62461390 |
| 47 | Optic disc pallor (HP:0000543) | 2.61590253 |
| 48 | Increased serum lactate (HP:0002151) | 2.60846554 |
| 49 | Abnormal hemoglobin (HP:0011902) | 2.59996481 |
| 50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59825547 |
| 51 | Bilateral microphthalmos (HP:0007633) | 2.59736691 |
| 52 | Lethargy (HP:0001254) | 2.48150197 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.46670695 |
| 54 | Partial duplication of the phalanx of hand (HP:0009999) | 2.45011017 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.44125322 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.44125322 |
| 57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.44125322 |
| 58 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.44125322 |
| 59 | Respiratory difficulties (HP:0002880) | 2.39428698 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.39394795 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.38856681 |
| 62 | Cerebral edema (HP:0002181) | 2.38233757 |
| 63 | Abnormality of alanine metabolism (HP:0010916) | 2.35282041 |
| 64 | Hyperalaninemia (HP:0003348) | 2.35282041 |
| 65 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.35282041 |
| 66 | Hypoproteinemia (HP:0003075) | 2.34559999 |
| 67 | Exercise intolerance (HP:0003546) | 2.33219395 |
| 68 | Nasolacrimal duct obstruction (HP:0000579) | 2.32810449 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.28364862 |
| 70 | Eczematoid dermatitis (HP:0000976) | 2.28258832 |
| 71 | True hermaphroditism (HP:0010459) | 2.27949478 |
| 72 | CNS demyelination (HP:0007305) | 2.25548908 |
| 73 | Purpura (HP:0000979) | 2.24671219 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.22909500 |
| 75 | Thrombocytosis (HP:0001894) | 2.22578126 |
| 76 | Abnormality of renal resorption (HP:0011038) | 2.20316719 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.17874413 |
| 78 | Rib fusion (HP:0000902) | 2.17693031 |
| 79 | Sparse eyelashes (HP:0000653) | 2.15592098 |
| 80 | IgM deficiency (HP:0002850) | 2.15547658 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.14611669 |
| 82 | Microretrognathia (HP:0000308) | 2.11546871 |
| 83 | Hypothermia (HP:0002045) | 2.11112836 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.09545351 |
| 85 | Abnormality of methionine metabolism (HP:0010901) | 2.07790904 |
| 86 | Abnormal pupillary function (HP:0007686) | 2.07347963 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 2.05960089 |
| 88 | Nephronophthisis (HP:0000090) | 2.04977601 |
| 89 | Abnormality of the anterior horn cell (HP:0006802) | 2.04612388 |
| 90 | Degeneration of anterior horn cells (HP:0002398) | 2.04612388 |
| 91 | Hyperglycinemia (HP:0002154) | 2.03754291 |
| 92 | Hypochromic anemia (HP:0001931) | 2.03687827 |
| 93 | Microcytic anemia (HP:0001935) | 2.02734156 |
| 94 | Parakeratosis (HP:0001036) | 2.02687704 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.01902876 |
| 96 | Recurrent skin infections (HP:0001581) | 2.01296697 |
| 97 | IgG deficiency (HP:0004315) | 2.01102713 |
| 98 | Congenital stationary night blindness (HP:0007642) | 2.01091433 |
| 99 | Colon cancer (HP:0003003) | 1.99510685 |
| 100 | Respiratory failure (HP:0002878) | 1.98829851 |
| 101 | Lactic acidosis (HP:0003128) | 1.98228981 |
| 102 | Abnormality of macrophages (HP:0004311) | 1.97395195 |
| 103 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96946892 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 1.96701467 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 1.96440630 |
| 106 | Leukodystrophy (HP:0002415) | 1.94781564 |
| 107 | Vasculitis (HP:0002633) | 1.94617560 |
| 108 | Abnormal lung lobation (HP:0002101) | 1.93693298 |
| 109 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93628767 |
| 110 | Increased serum ferritin (HP:0003281) | 1.93256012 |
| 111 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.92534197 |
| 112 | Absent thumb (HP:0009777) | 1.92424640 |
| 113 | Hypoplasia of the fovea (HP:0007750) | 1.90248936 |
| 114 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.90248936 |
| 115 | Optic neuritis (HP:0100653) | 1.90191697 |
| 116 | Retrobulbar optic neuritis (HP:0100654) | 1.90191697 |
| 117 | Dicarboxylic aciduria (HP:0003215) | 1.89634892 |
| 118 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89634892 |
| 119 | X-linked dominant inheritance (HP:0001423) | 1.89455379 |
| 120 | Palpitations (HP:0001962) | 1.88533331 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88499667 |
| 122 | Anomalous pulmonary venous return (HP:0010772) | 1.86913749 |
| 123 | Abnormality of serum amino acid levels (HP:0003112) | 1.86175852 |
| 124 | Cleft eyelid (HP:0000625) | 1.85807281 |
| 125 | Rectal fistula (HP:0100590) | 1.84726175 |
| 126 | Rectovaginal fistula (HP:0000143) | 1.84726175 |
| 127 | Meckel diverticulum (HP:0002245) | 1.82868994 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.80739683 |
| 129 | Abnormality of the ileum (HP:0001549) | 1.80508408 |
| 130 | Thyroiditis (HP:0100646) | 1.79987317 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 1.79976559 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.79572025 |
| 133 | Oral leukoplakia (HP:0002745) | 1.79067377 |
| 134 | Abnormality of T cells (HP:0002843) | 1.78054410 |
| 135 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.78045481 |
| 136 | Abnormality of vitamin B metabolism (HP:0004340) | 1.77806569 |
| 137 | Abnormality of T cell number (HP:0011839) | 1.76350866 |
| 138 | Pancytopenia (HP:0001876) | 1.75828690 |
| 139 | Hyperphosphaturia (HP:0003109) | 1.75682048 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75426340 |
| 141 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74992010 |
| 142 | Trismus (HP:0000211) | 1.74763256 |
| 143 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74672919 |
| 144 | Abnormality of chromosome stability (HP:0003220) | 1.74596056 |
| 145 | Glycosuria (HP:0003076) | 1.72778545 |
| 146 | Abnormality of urine glucose concentration (HP:0011016) | 1.72778545 |
| 147 | Gingival bleeding (HP:0000225) | 1.70647146 |
| 148 | Sclerocornea (HP:0000647) | 1.70305289 |
| 149 | Emotional lability (HP:0000712) | 1.69262116 |
| 150 | Abnormality of the renal medulla (HP:0100957) | 1.68268180 |
| 151 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.67789182 |
| 152 | Abnormality of the preputium (HP:0100587) | 1.67598442 |
| 153 | Hypoglycemic coma (HP:0001325) | 1.63762405 |
| 154 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.63760802 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.60997133 |
| 156 | Abnormality of the fovea (HP:0000493) | 1.60907458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.58443243 |
| 2 | VRK2 | 3.47048963 |
| 3 | ADRBK2 | 2.92108762 |
| 4 | PBK | 2.81814465 |
| 5 | GRK5 | 2.78522773 |
| 6 | MAP4K2 | 2.73225767 |
| 7 | GRK7 | 2.69249996 |
| 8 | MST4 | 2.68545238 |
| 9 | FRK | 2.64743624 |
| 10 | PIM2 | 2.54514327 |
| 11 | NUAK1 | 2.51405518 |
| 12 | GRK6 | 2.49221740 |
| 13 | ERN1 | 2.31128667 |
| 14 | TRIM28 | 2.21674596 |
| 15 | GRK1 | 2.15377838 |
| 16 | TXK | 2.05967460 |
| 17 | BLK | 2.04381971 |
| 18 | NEK1 | 2.00286762 |
| 19 | CSF1R | 1.98458906 |
| 20 | CDK12 | 1.98451875 |
| 21 | NME1 | 1.90401294 |
| 22 | ZAK | 1.89714045 |
| 23 | MAP3K14 | 1.87995344 |
| 24 | TGFBR2 | 1.86026464 |
| 25 | IKBKB | 1.80877028 |
| 26 | ACVR1B | 1.78825034 |
| 27 | IRAK4 | 1.77654909 |
| 28 | WNK3 | 1.72507830 |
| 29 | IRAK3 | 1.62268625 |
| 30 | STK16 | 1.60875563 |
| 31 | TBK1 | 1.52172182 |
| 32 | MOS | 1.48009970 |
| 33 | KIT | 1.47442009 |
| 34 | IKBKE | 1.46619899 |
| 35 | VRK1 | 1.45536029 |
| 36 | TESK2 | 1.44062152 |
| 37 | BCR | 1.44058536 |
| 38 | CDC7 | 1.39636019 |
| 39 | PLK3 | 1.37446299 |
| 40 | STK10 | 1.35778602 |
| 41 | TEC | 1.35541269 |
| 42 | TLK1 | 1.35436906 |
| 43 | MUSK | 1.34378940 |
| 44 | MATK | 1.34288159 |
| 45 | TYK2 | 1.29931047 |
| 46 | JAK3 | 1.28316938 |
| 47 | MAP4K1 | 1.22585685 |
| 48 | MKNK2 | 1.17433899 |
| 49 | ARAF | 1.14522608 |
| 50 | ZAP70 | 1.10147346 |
| 51 | BUB1 | 1.08270762 |
| 52 | WEE1 | 1.07639194 |
| 53 | KDR | 1.05813310 |
| 54 | PDK2 | 1.05615075 |
| 55 | ABL2 | 1.04862837 |
| 56 | PRKG2 | 1.02570873 |
| 57 | BMPR1B | 1.00574281 |
| 58 | CDK8 | 1.00186388 |
| 59 | EIF2AK2 | 0.99668601 |
| 60 | MAPKAPK5 | 0.98753952 |
| 61 | PINK1 | 0.98533239 |
| 62 | SYK | 0.98510932 |
| 63 | INSRR | 0.97902393 |
| 64 | OXSR1 | 0.96965251 |
| 65 | CSNK1G3 | 0.94990855 |
| 66 | BRSK2 | 0.94755826 |
| 67 | BCKDK | 0.94085041 |
| 68 | PLK4 | 0.92990792 |
| 69 | BTK | 0.92625337 |
| 70 | WNK4 | 0.90524729 |
| 71 | ERBB3 | 0.89724613 |
| 72 | NLK | 0.89543350 |
| 73 | MAPK7 | 0.88864781 |
| 74 | TAF1 | 0.88415744 |
| 75 | IRAK2 | 0.88215043 |
| 76 | PIM1 | 0.88146971 |
| 77 | CDK7 | 0.85291277 |
| 78 | CSNK1G2 | 0.84170517 |
| 79 | MAP3K12 | 0.81567179 |
| 80 | CSNK1G1 | 0.80939027 |
| 81 | EIF2AK1 | 0.78147349 |
| 82 | ITK | 0.77115534 |
| 83 | MAPK13 | 0.76977568 |
| 84 | NEK9 | 0.76795915 |
| 85 | PLK2 | 0.76419467 |
| 86 | MAP3K4 | 0.75967636 |
| 87 | CDK19 | 0.75794058 |
| 88 | LCK | 0.72687645 |
| 89 | CSK | 0.72535768 |
| 90 | LRRK2 | 0.71805089 |
| 91 | MYLK | 0.71073411 |
| 92 | ATR | 0.70283953 |
| 93 | HIPK2 | 0.69470175 |
| 94 | CSNK1A1L | 0.69206273 |
| 95 | STK39 | 0.67963063 |
| 96 | LYN | 0.67552667 |
| 97 | BMPR2 | 0.67315381 |
| 98 | FLT3 | 0.67300762 |
| 99 | SRPK1 | 0.66779752 |
| 100 | DYRK3 | 0.65747067 |
| 101 | EIF2AK3 | 0.64552681 |
| 102 | CHUK | 0.64461457 |
| 103 | ADRBK1 | 0.63921317 |
| 104 | TAOK3 | 0.63699326 |
| 105 | MAP2K6 | 0.62155630 |
| 106 | DYRK2 | 0.61339989 |
| 107 | PRKCD | 0.60744884 |
| 108 | MKNK1 | 0.59589739 |
| 109 | CCNB1 | 0.57422542 |
| 110 | PIK3CG | 0.57273280 |
| 111 | CSNK2A2 | 0.55682845 |
| 112 | OBSCN | 0.55591638 |
| 113 | STK3 | 0.55269124 |
| 114 | DAPK1 | 0.55201557 |
| 115 | TSSK6 | 0.54522475 |
| 116 | TTK | 0.52693837 |
| 117 | STK4 | 0.50782025 |
| 118 | IRAK1 | 0.50655167 |
| 119 | PASK | 0.50485939 |
| 120 | TNK2 | 0.49612118 |
| 121 | PHKG1 | 0.48390909 |
| 122 | PHKG2 | 0.48390909 |
| 123 | PAK4 | 0.48261737 |
| 124 | MAP2K7 | 0.48173208 |
| 125 | RPS6KB2 | 0.47409852 |
| 126 | TNIK | 0.47333721 |
| 127 | RPS6KA5 | 0.44316496 |
| 128 | ILK | 0.43752682 |
| 129 | CDK3 | 0.43622990 |
| 130 | PAK3 | 0.43487710 |
| 131 | CSNK2A1 | 0.42630258 |
| 132 | MAPK4 | 0.42364919 |
| 133 | LIMK1 | 0.42226220 |
| 134 | YES1 | 0.41709428 |
| 135 | PRKCQ | 0.41391663 |
| 136 | MAPKAPK2 | 0.40670845 |
| 137 | AURKB | 0.40209815 |
| 138 | MARK3 | 0.39923300 |
| 139 | PRKCE | 0.38461726 |
| 140 | RIPK4 | 0.37825975 |
| 141 | ATM | 0.36917575 |
| 142 | TESK1 | 0.36470629 |
| 143 | IGF1R | 0.36006687 |
| 144 | PLK1 | 0.35076173 |
| 145 | RPS6KA4 | 0.34710487 |
| 146 | AURKA | 0.34442793 |
| 147 | NEK2 | 0.33779921 |
| 148 | STK38L | 0.31613955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.06110666 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.96185854 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.64249377 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.55733388 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.55152905 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.48244930 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35713800 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.04096270 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.91962269 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.76718821 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76215791 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.68655737 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.68636999 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64878780 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.60384628 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57334265 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.56893297 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.56764559 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56747687 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56675017 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51595412 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.51166958 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44147017 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43428379 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41998731 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36812444 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32037571 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.27108655 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22731906 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22409038 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20010910 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15680767 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15115404 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14772633 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14471359 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13457984 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10872475 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.06328345 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.06244533 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.04769911 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04767776 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03949410 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.01213411 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01052931 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99785191 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99198009 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98895278 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97898830 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97874301 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96424512 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96139642 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93771422 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93306606 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93088095 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93008483 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92342022 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91445098 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90226716 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.90018544 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89643893 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 0.87824020 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87395292 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87188994 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.86948590 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86574436 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.85910815 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85814404 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.85597219 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83747285 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.79743937 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.79597804 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78782275 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78699133 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78332183 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77432800 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76257606 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75860915 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73734718 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72698850 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72009456 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70560924 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70335986 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70144614 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69017715 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68995986 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65673234 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65652078 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.65627159 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64190749 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63188827 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60450941 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59932434 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58255971 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.57400825 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53660368 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53541431 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50463977 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.49210110 |
| 99 | Cell cycle_Homo sapiens_hsa04110 | 0.48642225 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.48321001 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45766966 |
| 102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45431411 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45348253 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.44309897 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43314241 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42583391 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42335927 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41502332 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40581457 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40576312 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40295776 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39720286 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39339571 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38009280 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37187838 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37154108 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36302136 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35899334 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35528360 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33047630 |
| 121 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31439279 |
| 122 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30855645 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30239928 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29838341 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25074158 |

